Mallinckrodt Plc (MNKT)

[VegasMcKnight]

Playing on the dip right here. Good price and very short term.

[VegasMcKnight]

From what I saw the past two days, it was shorted right after a halt past 12:30

[ClayTrader]

* * $MNK Video Chart 03-16-2020 * *

Link to Video - click here to watch the technical chart video

[StockNinja33]

Bought 2000 at 2.10

[dirtydozen911]

back under $3....time to keep an eye on MNK...….manipulation of all the bio`s since the virus breakout is incredible!

$$$$$$$$$$$$ MNK $$$$$$$$$......gl

[ClayTrader]

* * $MNK Video Chart 03-12-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $MNK Video Chart 03-11-2020 * *

Link to Video - click here to watch the technical chart video

[dirtydozen911]

missed the dip....but did catch some $2.18`s a few minutes later

$$$$$$$$$$$$$$$$$$$$ MNK $$$$$$$$$$$$$$$....glta

[dirtydozen911]

MNK at $2.88, and falling.....getting ready to add....glta

[dirtydozen911]

this really took a beating today!.....probably more than deserved...mnk generics subsids will pay opiod claims to 47 states in a chapter 11 case , that the parties and gov`t are on the same page......1.6+ billion , over 8 years.....they are one of the smaller defendants in the opiod mess, but the first to offer settlement.....parent co...MNK.plc would not be involved.....have an impressive pipeline, but no one dares buy in because of debt burden.....if this drops down to $2.50 , it could be worth the risk...…………BIG RISK!!...GLTA

[BBANBOB]

THEY PROBABLY ARE TODAY!!!!!!!!!!!!!!!!!

Especially since they saw yesterday just how fast this can fly

[ClayTrader]

* * $MNK Video Chart 02-25-2020 * *

Link to Video - click here to watch the technical chart video

[ctrumabll]

Seriously, wouldn't any short seller be covering and banking their gains at this point?

Really, the ENSSFM do not control everything.

[ClayTrader]

* * $MNK Video Chart 02-24-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $MNK Video Chart 02-20-2020 * *

Link to Video - click here to watch the technical chart video

[ctcollins]

February 10, 2020 02:43 PM ET

It appears more and more likely a case against opioid manufacturers and distributors will proceed to trial in New York state, keeping Bank of America bearish on the companies despite recent performance.
The recent denial of a motion to delay the case — which the state brought against the companies —and other factors make it look likely it will go to trial as scheduled March 20, BofA Securities analyst Jason Gerberry said in a Monday note.

That's leading Gerberry to keep Underperform ratings on industry stocks in his coverage, including opioid manufacturers Teva Pharmaceutical Industries Ltd (NYSE:TEVA) and Mallinckrodt PLC (NYSE:MNK), even though they've generally outperformed the market.

What To Know About The New York Opioid Case
Lawsuits against opioid makers and distributors from eight New York counties were consolidated into one case brought by the New York attorney general in 2017.

Initially the case was focused on Purdue Pharma, which New York accused of helping create the opioid epidemic, but the company went bankrupt. That led to the case changing focus to a broader list of allegations against other manufacturers and distributors.

Gerberry said the case has gotten investor attention recently as  a trial has approached with no updates on potential settlements.
"The ongoing opioid litigation remains in its early innings and the financial risk remains difficult to quantify, which is a key reason we are Underperform rated on the companies with opioid exposure in our coverage," the analyst said.

Other Opioid Cases

So far, two other cases elsewhere in the country have ended in settlements. In another case, in Oklahoma, a judge ordered Johnson & Johnson (NYSE:JNJ) to pay more than $500 million for its alleged role in the epidemic.

A proposed $48-billion settlement framework was announced in October, but most states have declined to participate in the settlement approach.
Gerberry said downside risk isn't fully priced in to Teva and Mallinckrodt as the New York trial approaches, but also because other state litigation, including a case in Ohio, persists.
Also, it has been months since the settlement framework, but few states have seemed interested. Without a global settlement, even if states do settle in piecemeal fashion, it could stretch out costs over a long time, he said.

Gerberry also noted a recent buy-side survey that "suggests institutional investors are bearish on opioid-exposed names ahead of (the New York) case, which runs counter to recent outperformance."
Besides New York, other cases against the opioid industry that could go to trial in 2020 include those in Ohio, Alabama, Mississippi, Louisiana and Washington.

[ClayTrader]

* * $MNK Video Chart 02-04-2020 * *

Link to Video - click here to watch the technical chart video

[ClayTrader]

* * $MNK Video Chart 01-22-2020 * *

Link to Video - click here to watch the technical chart video

[ourword]

[ourword]

Golden cross??!!

[ClayTrader]

* * $MNK Video Chart 01-21-2020 * *

Link to Video - click here to watch the technical chart video

[BBANBOB]

YO SHORTS ya don't even need to be able to read tea leaves to see whats happening here!!!!!!!

COVERRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRRR

[ClayTrader]

* * $MNK Video Chart 01-16-2020 * *

Link to Video - click here to watch the technical chart video

[BBANBOB]

The news of the CEO's comment about being close to a resolution of the lawsuits caused this move! And LOW and BEHOLD someone knew about that BEFORE HAND!!!!!!!!!!!!!!!!!

Now what do ya think will happen when it is actually announced they have settled???????????? MY WAG is back and north of $10 and in a flash!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Which in turn will cause a short squeeze even more than what is going on right now!

Even if they have been able to whittle it down to say 25 mill short it will be epic in nature!!!!!!! $ 10 may be far to low in a squeeeeeeeze

ALL imho

[BBANBOB]

I don't think this thing is ANYWHERE NEAR OVER actually only starting to recover!!!!!!!!!!!!!

[jhdf51]

Great call...i *F ucked up.

JHD

[BBANBOB]

KNOCK KNOCK SHORTS anyone HOME???????????????????????????

[ClayTrader]

* * $MNK Video Chart 01-15-2020 * *

Link to Video - click here to watch the technical chart video

[BBANBOB]

DO any here have the last 3 or four short reports and how much they have gone down/up

I can't find their short interests reports for the last 4 or 5 reports

[BBANBOB]

WATCH for the SHORT REPORT to show a MARKED DECREASE in short share!!!!!!!!

There are only 2 ways to obtain shares in a company. SCARE WEAK HOLDERS out of them tanking the PPS, OR OR OR pay a fair price or better price and buy em!!!!!!!!!!!!!

WAG is we close @ HOD

[BBANBOB]

SHORTS been WARNED NOW 2 times!!!!!!!!!!!!!!!

If IF IF there is any validity to a possible buy out one has to understand that with this having been a $16 stock a year ago it is undervalued and a buy out would almost HAVE TO PAY a premium to what we are trading today like maybe IN THE MIDDLE or close like 8-10.

FDA and lawsuits can NOT put tall the drug co's out of bidness, they WILL IMHO reach an amicable middle ground, fines but not so HUGE they take co's down. ALL imho

[CHARLIE125]

MNK GOING TO PARABOLIC
TEVA WILL BUY MNK
MALLINCROCDT IS ON FIRE THIS MORNING.TEVA IS INTERESTED IN MNK
MORE EYES ARE IN
ginantic upside today for MNK SURE!!

[denzelwashington]

Acthar seems to have competition on the horizon. The Swedish company SynAct Pharma has found what melanocortin receptors that work and which that really doesn't do anything.

The mechanism of action is not know in Acthar, 50+ years after its inception. All we know is that it targets MC1R-MC5R.

SynAct Pharma has recognized that MC1R and MC3R are the two MCs that are pulling the real weight in terms of efficacy. They will shortly announce interim analysis in their phase II-study. I believe that this will be the death blow to Acthar, but perhaps they are in talks of maybe acquiring SynAct in some form?

Anyone with more info?

[ourword]

MNK the most important numbers you should know

[BBANBOB]

again short were warned here!!!!!!!!!!!!!!!

THEY WILL ONLY KEEP THE BOATS lowered THIS low FOR so long!!!!!!!!!!!!!!!!!!


TAKE ADVANTAGE OF IT OR THEY WILL TAKE ADVANTAGE OF YOU AND IN A BIG WAY

imho THIS IS OVER 6$ IN LESS THAN 6 MONTHS!!!!!!!! AND MAYBE MUCH HIGHER

[ctcollins]

12/10/2019 S&P upgrades Mallinckrodt to "CCC"

[ClayTrader]

For anyone who actually wants to improve as a trader, I'd encourage you to watch this https://claytrader.com/videos/trading-confirmation-bias/ it 100% explains what this person is suffering from.

[kmerrill057]

You’re right. It isn’t strange that every time you post a chart the stock tanks the next day ??

[ClayTrader]

go study confirmation bias

[kmerrill057]

The clay trader curse is real

[whytestocks]

News: $MNK Mallinckrodt plc Announces Final Results of Exchange Transactions

STAINES-UPON-THAMES, United Kingdom , Dec. 5, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE:  MNK) today announced (1) the final results of the previously announced offers by its wholly owned subsidiaries, Mallinckrodt International Finance S.A. and Mallinckrodt CB LLC (the "Issue...

Read the whole news MNK - Mallinckrodt plc Announces Final Results of Exchange Transactions

[ClayTrader]

* * $MNK Video Chart 12-04-2019 * *

Link to Video - click here to watch the technical chart video

[BBANBOB]

WARNED 21 days ago!!!!!!!!!!!!!!!!!!!


Shorts are playing with FIRE HERE Lit Dynamite here.

This thing has VW/PORSCHE written all over it

Also can someone EXPLAIN to me how institutional's can own 126% of a company

[whytestocks]

News: $MNK Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease

STAINES-UPON-THAMES, United Kingdom , Nov. 26, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced findings from a large retrospective study of Acthar ® Gel (repository corticotropin injection) in the treatment of the respirator...

Find out more MNK - Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease

[ClayTrader]

* * $MNK Video Chart 11-25-2019 * *

Link to Video - click here to watch the technical chart video

[dirtydozen911]

this has "climbed the stairs all week".....new lawsuits filed......should drop back under $3 next week.....I`m back in around 270...280....glta

[ctcollins]

Endo International (ENDP) and Mallinckrodt (MNK) have been sued by West Virginia Attorney General Patrick Morrisey in relation to opioid addiction risks.

Two separate suits were filed in Boone County court and are seeking monetary damages.

The lawsuits accuse the companies of contributing "to the opioid crisis by individually engaging in strategic campaigns to deceive prescribers and misrepresent the risks and benefits of opioid painkillers," according to the AG's statement.
It said the companies "mischaracterized and failed to disclose the serious risk of addiction, overstated the benefits of chronic opioid therapy and promoted higher dosage amounts without disclosing inherently greater risks."

[BBANBOB]

THANK YOU

[Trend-Setter]

MNK prevailed.
"On November 13, 2019, the Patent Trial and Appeal Board of the United States Patent and Trademark Office (the “Board”) issued a written decision in the inter partes review (“IPR”) action that was brought by Mallinckrodt Pharmaceuticals Ireland Limited (“Mallinckrodt”) against BioVie Inc. (“BioVie” or “Company”). In that action, Mallinckrodt sought to invalidate BioVie’s patent (U.S. Pat. No. 9,655,945, “Treatment of Ascites”) (the “’945 Patent”). In its decision, the Board determined that all claims of the ‘945 Patent were not patentable because they were either anticipated or obvious in light of prior art. The Board also denied BioVie’s Motion to Amend the claims on similar grounds. The result of the Board’s decision is that the ‘945 patent is no longer valid or enforceable. Acuitas Group Holdings, LLC was aware of this patent challenge when it purchased a majority ownership interest in the company in July 2018".

https://www.sec.gov/Archives/edgar/data/1580149/000152013819000459/bivi-20191115_8k.htm

poor thing!

[BBANBOB]

I'm sorry MY BAD I must have gotten a link mixed up and lost the original link